R Rigolio
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 5
- PARP inhibition in cancer therapy 4
- Cytokine Signaling Pathways and Interactions 3
-
- Cell death mechanisms and regulation 4
- Co-authors
- Guido Cavaletti (21 shared papers)Gabriella Nicolini (13 shared papers)Mariarosaria Miloso (10 shared papers)G Tredici (9 shared papers)Giulio Sancini (4 shared papers)Francesca Re (3 shared papers)G Fumagalli (1 shared paper)C Meregalli (1 shared paper)
- Journals
- International Journal of Molecular Sciences (3 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)Molecules (2 papers)Scientific Reports (2 papers)Journal of Neuroimmunology (1 paper)
- Partner nations
- ItalySpainUnited States
In The Last Decade
R Rigolio
39 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 102
- Geriatrics and Gerontology 66
- Biomaterials 220
- Pharmaceutical Science 90
- Neurology 99
- Structural Biology 17
Countries citing papers authored by R Rigolio
This map shows the geographic impact of R Rigolio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Rigolio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Rigolio more than expected).
Fields of papers citing papers by R Rigolio
This network shows the impact of papers produced by R Rigolio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Rigolio. The network helps show where R Rigolio may publish in the future.
Co-authors
The 25 scholars most cited alongside R Rigolio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 146 | |
| 2 | 2017 | 133 | |
| 3 | 2021 | 129 | |
| 4 | 2001 | 79 | |
| 5 | 2017 | 77 | |
| 6 | 2013 | 75 | |
| 7 | 2015 | 50 | |
| 8 | 2012 | 48 | |
| 9 | 2014 | 44 | |
| 10 | 2002 | 43 | |
| 11 | 2019 | 39 | |
| 12 | 2015 | 36 | |
| 13 | 2009 | 36 | |
| 14 | 2005 | 35 | |
| 15 | Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat. | 2003 | 33 |
| 16 | 2015 | 30 | |
| 17 | 2019 | 27 | |
| 18 | 2019 | 26 | |
| 19 | 2017 | 25 | |
| 20 | 2016 | 22 |
About R Rigolio
R Rigolio is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Neurology and Hematology, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (6 papers), Cancer Treatment and Pharmacology (5 papers), Multiple Sclerosis Research Studies (4 papers), Cell death mechanisms and regulation (4 papers), PARP inhibition in cancer therapy (4 papers), Systemic Lupus Erythematosus Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Geriatrics and Gerontology (66 citations), Biomaterials (220 citations), Pharmaceutical Science (90 citations), Neurology (99 citations) and Structural Biology (17 citations). R Rigolio has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Guido Cavaletti, Gabriella Nicolini, Mariarosaria Miloso, G Tredici, Giulio Sancini, Francesca Re, G Fumagalli, C Meregalli, L Monza and Roberta Dal Magro. Their work appears in journals such as International Journal of Molecular Sciences, Nanomedicine Nanotechnology Biology and Medicine, Molecules, Scientific Reports and Journal of Neuroimmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.